Abstract
Introduction
Orthostatic hypotension (OH) and atrial fibrillation (AF) are both regarded as independent risk factors for transient ischemic attack (TIA). However, the clinical implication of OH in the presence of AF is unclear. This study investigates, for the first time, the association between blood pressure (BP), OH and mortality in a cohort of patients with AF and TIA symptoms.
Aim
To investigate the incidence of the association between OH, AF and TIA.
Methods
This retrospective observational study utilised the Leicester one-stop transient TIA clinic patient database to consider the initial systolic and diastolic BP of 688 patients with a diagnosis of AF. The primary outcome was time until death. Covariant measures included status of AF diagnosis (known or new AF), cardiovascular risk factors, and primary clinic diagnosis [cerebrovascular (CV) versus non-cerebrovascular (non-CV)]. Statistical models adjusted for sex, age, previous AF diagnosis.
Results
Mortality rate was higher in the over 85 age group [191.5 deaths per 1000 person years (py) (95% CI 154.0–238.1)] and lower in the aged 75 and younger age group [40.0 deaths per 1000 py (95% CI 27.0–59.2)] compared to intermediate groups. A 10 mmHg increase in supine diastolic BP was associated with a significant reduction in the hazard of mortality for patients suspected of TIA with AF [adjusted HR 0.79 (95% CI 0.68–0.92), p < 0.001]. The mortality rate for patients with OH was 119.0 deaths per 1000 py compared with a rate of 98.0 for patients without OH (rate ratio 1.2, p = 0.275).
Conclusion
Higher diastolic BP may be a marker for reduced mortality risk in patients with a previous AF diagnosis and non-CV diagnosis. Lower diastolic BP and the presence of AF pertain to a higher mortality risk. This study raises the importance of opportunistic screening for both OH and AF in patients presenting to TIA clinic.
Similar content being viewed by others
References
Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors J, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064–89.
Cruz-Flores S. Acute stroke and transient ischemic attack in the outpatient clinic. Med Clin N Am. 2017;101:479–94.
Royal College of Physicians (2014) Sentinel Stroke National Audit Programme (SSNAP): Clinical Audit April–June 2015 Public Report. Royal College of Physicians London.
Cordonnier C, Leys D. Stroke: the bare essentials. Pract Neurol. 2008;8:263–72.
NICE (2017) Stroke and TIA, secondary prevention following stroke and TIA, NICE guideline CKS. https://cks.nice.org.uk/stroke-and-tia#!scenario:2. Accessed 05 July 2019.
Phipps MS, Schmid AA, Kapoor JR, Peixoto AJ, Williams LS, Bravata DM. Orthostatic hypotension among outpatients with ischemic stroke. J Neurol Sci. 2012;314:62–5.
Kwok C, Ong A, Potter J, Metcalf A, Myint P. TIA, stroke and orthostatic hypotension: a disease spectrum related to ageing vasculature? Int J Clin Pract. 2014;68:705–13.
McNicholas T, Tobin K, O’Callaghan S, Kenny R. Is orthostatic hypotension more common in individuals with atrial fibrillation? Findings from the Irish Longitudinal Study on Ageing (TILDA). Age Ageing. 2017;46:1006–10.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–71.
Vokó Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JC, Breteler MM. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension. 1999;34:1181–5.
Strandgaard S, Paulson OB. Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens. 1989;2:486–92.
Wijkman M, Länne T, Östgren CJ. Nystrom FH Diastolic orthostatic hypertension and cardiovascular prognosis in type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol. 2016;15:83.
Logan IC, Witham MD. Efficacy of treatments for orthostatic hypotension: a systematic review. Age Ageing. 2012;41:587–94.
Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987–1996. Stroke. 2000;31:2307–13.
Agarwal SK, Alonso A, Whelton SP, Soliman EZ, Rose KM, Chamberlain AM, Simpson RJ Jr, Coresh J, Heiss G. Orthostatic change in blood pressure and incidence of atrial fibrillation: results from a bi-ethnic population based study. PLoS One. 2013;8:e79030.
Fedorowski A, Wahlstrand B, Hedner T, Melander O. Systolic and diastolic component of orthostatic hypotension and cardiovascular events in hypertensive patients: the Captopril Prevention Project. J Hypertens. 2014;32:75–81.
Vanassche T, Lauw MN, Eikelboom JW, Healey JS, Hart RG, Alings M, Avezum A, Díaz R, Hohnloser SH, Lewis BS. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J. 2014;36:281–8.
Taylor BC, Wilt TJ, Welch HG. Impact of diastolic and systolic blood pressure on mortality: implications for the definition of “normal”. J Gen Int Med. 2011;26:685.
Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2:474–80.
Kamel H, Okin PM, Elkind MS, Iadecola C. Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke. 2016;47:895–900.
Shaikh AY, Wang N, Yin X, Larson MG, Vasan RS, Hamburg NM, Magnani JW, Ellinor PT, Lubitz SA, Mitchell GF. Relations of arterial stiffness and brachial flow-mediated dilation with new-onset atrial fibrillation: the Framingham Heart Study. Hypertension. 2016;68:590–6.
Milazzo V, Maule S, Di Stefano C, Tosello F, Totaro S, Veglio F, Milan A. Cardiac organ damage and arterial stiffness in autonomic failure: comparison with essential hypertension’. Hypertension. 2015;66:1168–75.
Bellien J, Favre J, Iacob M, Gao J, Thuillez C, Richard V, Joannides R. Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans. Hypertension. 2010;55:674–80.
Kallistratos M, Poulimenos L, Manolis A. Atrial fibrillation and arterial hypertension. Pharm Res. 2018;128:322–6.
Petre I, Onciul S, Iancovici S, et al. Left atrial strain for predicting atrial fibrillation onset in hypertensive patients. High Blood Press Cardiovasc Prev. 2019;26:331–7.
Bacchini M, Bonometti S, Del Zotti F, et al. Opportunistic screening for atrial fibrillation in the pharmacies: a population-based cross-sectional study. High Blood Press Cardiovasc Prev. 2019;26:339–44.
Funding
This work was supported by a Collaborations for Leadership in Applied Health Research and Care Phase V Grant (East Midlands). JSM is an NIHR Clinical Lecturer at the Department of Cardiovascular Sciences, University of Leicester. Professor TG Robinson is a National Institute for Health Research Senior Investigator. The funders stated above did not have any involvement in the design, conduct, reporting or decision to submit for publication.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Additional information
Joint Senior Authors: Amit K. Mistri, David J. Eveson.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mankoo, A.S., Minhas, J.S., Coles, B. et al. Clinical Relevance of Orthostatic Hypotension in Patients with Atrial Fibrillation and Suspected Transient Ischemic Attack. High Blood Press Cardiovasc Prev 27, 93–101 (2020). https://doi.org/10.1007/s40292-020-00363-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40292-020-00363-4